Literature DB >> 9713063

An inner city preschool visual screening programme: long-term visual results.

R J Bowman1, T H Williamson, R G Andrews, T C Aitchison, G N Dutton.   

Abstract

AIMS: The aim of this study was to investigate the long-term outcome of the treatment of amblyopia as a sequel to preschool screening, which has not hither-to been described.
METHODS: All patients originally referred from a preschool screening programme were recalled for examination by letter. 255 patients were reviewed at least 4 years after discharge of which 88 were definitely amblyopic at presentation and 107 were not amblyopic at presentation and were used as controls.
RESULTS: 79% of the amblyopes improved or maintained visual acuity after discharge but this was reduced to 42% after an age induced increase (estimated from the controls) was compensated for. The mean drop in visual acuity in the amblyopic eyes which deteriorated was 0.23 (SD 0.15) logMAR units. Stepwise multiple linear regression showed that the best single predictor of post-discharge deterioration in visual acuity was the improvement in visual acuity seen during treatment (R2 = 19%). Eccentric fixation at time of follow up (increasing R2 to 47%) and good presenting acuity (further raising R2 to 57%) contributed additional information, and were both associated with greater post-discharge deterioration in visual acuity.
CONCLUSIONS: The majority of amblyopes who attended for follow up maintained or improved their visual acuities after discharge. Those patients who demonstrated deterioration of their amblyopia had usually improved well during the programme and were often fixating eccentrically at follow up.

Entities:  

Mesh:

Year:  1998        PMID: 9713063      PMCID: PMC1722604          DOI: 10.1136/bjo.82.5.543

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Stability of visual acuity in amblyopic patients after visual maturity.

Authors:  W E Scott; C F Dickey
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

2.  [Late results from amblyopia treatment].

Authors:  H Aichmair; R G Frey
Journal:  Klin Monbl Augenheilkd       Date:  1968-08       Impact factor: 0.700

3.  The period of susceptibility to the physiological effects of unilateral eye closure in kittens.

Authors:  D H Hubel; T N Wiesel
Journal:  J Physiol       Date:  1970-02       Impact factor: 5.182

4.  "Conventional" occlusion in the treatment of squint amblyopia. A ten year follow-up.

Authors:  E Gregersen; E Rindziunski
Journal:  Acta Ophthalmol (Copenh)       Date:  1965

5.  Anisometropic amblyopia.

Authors:  P J Kutschke; W E Scott; R V Keech
Journal:  Ophthalmology       Date:  1991-02       Impact factor: 12.079

6.  When is it safe to stop patching?

Authors:  J G Oster; J W Simon; P Jenkins
Journal:  Br J Ophthalmol       Date:  1990-12       Impact factor: 4.638

7.  Factors affecting long term results of successfully treated amblyopia: initial visual acuity and type of amblyopia.

Authors:  S Levartovsky; M Oliver; N Gottesman; M Shimshoni
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

8.  Assessment of an inner city visual screening programme for preschool children.

Authors:  T H Williamson; R Andrews; G N Dutton; G Murray; N Graham
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

9.  Practical management of amblyopia.

Authors:  F C Ching; M M Parks; D S Friendly
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1986 Jan-Feb       Impact factor: 1.402

10.  Severe visual loss resulting from occlusion therapy for amblyopia.

Authors:  J W Simon; M M Parks; E C Price
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1987 Sep-Oct       Impact factor: 1.402

View more
  9 in total

1.  Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified?

Authors:  M Cleary
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Screening for visual impairment in children younger than age 5 years: recommendation statement.

Authors: 
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

3.  Static and dynamic measurements of accommodation in individuals with down syndrome.

Authors:  Heather A Anderson; Ruth E Manny; Adrian Glasser; Karla K Stuebing
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

4.  Minus-lens-stimulated accommodative amplitude decreases sigmoidally with age: a study of objectively measured accommodative amplitudes from age 3.

Authors:  Heather A Anderson; Gloria Hentz; Adrian Glasser; Karla K Stuebing; Ruth E Manny
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-07       Impact factor: 4.799

5.  Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.

Authors:  Michael X Repka; Raymond T Kraker; Jonathan M Holmes; Allison I Summers; Stephen R Glaser; Carmen N Barnhardt; David R Tien
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

6.  A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.

Authors:  Michael X Repka; Raymond T Kraker; Roy W Beck; Jonathan M Holmes; Susan A Cotter; Eileen E Birch; William F Astle; Danielle L Chandler; Joost Felius; Robert W Arnold; D Robbins Tien; Stephen R Glaser
Journal:  Arch Ophthalmol       Date:  2008-08

7.  Does amblyopia affect educational, health, and social outcomes? Findings from 1958 British birth cohort.

Authors:  J S Rahi; P M Cumberland; C S Peckham
Journal:  BMJ       Date:  2006-03-06

8.  Minus lens stimulated accommodative lag as a function of age.

Authors:  Heather A Anderson; Adrian Glasser; Karla K Stuebing; Ruth E Manny
Journal:  Optom Vis Sci       Date:  2009-06       Impact factor: 1.973

9.  Outcomes of 6 hour part-time occlusion treatment combined with near activities for unilateral amblyopia.

Authors:  Kyoung Soo Park; Yoon Hee Chang; Kyung Doo Na; Samin Hong; Sueng Han Han
Journal:  Korean J Ophthalmol       Date:  2008-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.